Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $34,314 | $45,451 | $106,716 | $73,832 |
| - Cash | $8,923 | $21,649 | $9,345 | $15,014 |
| + Debt | $2,227 | $2,790 | $3,552 | $2,509 |
| Enterprise Value | $27,618 | $26,592 | $100,924 | $61,327 |
| Revenue | $12,795 | $8,017 | $9,582 | $892 |
| % Growth | 59.6% | -16.3% | 974.6% | – |
| Gross Profit | $6,371 | $7,008 | $2,436 | $297 |
| % Margin | 49.8% | 87.4% | 25.4% | 33.3% |
| EBITDA | -$32,034 | -$22,859 | -$36,492 | -$18,287 |
| % Margin | -250.4% | -285.1% | -380.8% | -2,050.9% |
| Net Income | -$33,129 | -$24,039 | -$36,378 | -$19,807 |
| % Margin | -258.9% | -299.8% | -379.6% | -2,221.3% |
| EPS Diluted | -0.2 | -0.2 | -0.36 | -0.41 |
| % Growth | 0% | 44.4% | 12.2% | – |
| Operating Cash Flow | -$20,400 | -$24,532 | -$30,075 | -$14,774 |
| Capital Expenditures | -$1,744 | -$2,693 | -$6,095 | -$3,826 |
| Free Cash Flow | -$22,144 | -$27,225 | -$36,170 | -$18,600 |